2021 Webinar: Microbiome in NASH and Cirrhosis-Microbiome in NASH and Cirrhosis

Video Transcription

Video Summary

In this webinar, three clinician scientists discuss the role of the microbiome in non-alcoholic fatty liver disease (NAFLD) and cirrhosis. They highlight that the composition and function of the gut microbiome play important roles in the development and progression of NAFLD and cirrhosis. They explain that factors such as diet, antibiotic usage, hygiene, and lifestyle can influence the composition of the gut microbiome. They also discuss the potential for modulating the gut microbiome as a therapeutic approach for these liver diseases. For example, they mention the use of pre- and probiotics, antibiotics, and fecal microbiota transplantation (FMT). The scientists also touch on the role of other microorganisms, including fungi and viruses, in liver disease. They explain that the microbiome can affect the immune response in the liver, with both innate and adaptive immune responses playing a role in NAFLD and cirrhosis. Overall, the webinar emphasizes the importance of understanding and targeting the microbiome for the prevention and treatment of liver diseases. However, more research is needed to fully understand the complexities of the gut microbiome and its interactions with the liver.

Keywords

webinar

microbiome

NAFLD

cirrhosis

gut microbiome

therapeutic approach

FMT

microorganisms

immune response

liver